[Fibrinolytic activity in patients undergoing hepatic transplantation].
Bleeding complications during liver transplantation have been attributed to accelerated fibrinolysis. In order to determine its cause, 11 adults (mean age: 38.9 +/- 13.2 yr) undergoing liver transplantation were studied. There were three groups of patients: cirrhosis (n = 4), fulminating hepatitis (n = 4) and one group including a primary biliary cirrhosis, a hepatic metastasis and a hepatoma. The following factors were studied in the immediate preoperative period, at different surgical times throughout the procedure and 2-3 h after the end of the abdominal sutures: platelet count, prothrombin concentration, fibrinogen, activated kephalin time, factors II, V, VII + X and VIIIc, antithrombin III, protein C, D-dimers, fibrinogen and fibrin degradation products (PDF), plasma plasminogen, tissue plasminogen activator (tPA) and the fast tPA inhibitor (PAi). Preoperatively, only the two patients with hepatic cancer had a normal haemostatic profile. Throughout the procedure, all patients had only moderate changes in platelets, coagulation factors and their inhibitors, and plasminogen, because platelet concentrates and fresh frozen plasma were transfused. Levels of tPA rose, becoming very high during the anhepatic period and just after graft reperfusion. An abrupt fall occurred at the end of surgery. There were important individual differences in tPA activity. PAi activity was low during the preanhepatic and anhepatic stages, rising rapidly after revascularization.(ABSTRACT TRUNCATED AT 250 WORDS)
Houvenaeghel
M
M
Département d'Anesthésie-Réanimation, Hôpital de la Conception, Marseille.
Andréoli
S
S
Achilli-Cornesse
M E
ME
Boutière
B
B
Arnoux
D
D
Le Treut
Y P
YP
Manelli
J C
JC
D001779:Blood Coagulation Factors / Q000032:analysis*; D005342:Fibrinolysis; D006023:Glycoproteins / Q000378:metabolism; D006470:Hemorrhage / Q000209:etiology; D006801:Humans; D007431:Intraoperative Complications; D007432:Intraoperative Period; D016031:Liver Transplantation; D010960:Plasminogen Activators / Q000037:antagonists & inhibitors; D015849:Plasminogen Inactivators; D010976:Platelet Count; D010959:Tissue Plasminogen Activator / Q000378:metabolism
D001779:Blood Coagulation Factors; D006023:Glycoproteins; D015849:Plasminogen Inactivators; D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator
Activité fibrinolytique chez les patients opérés pour transplantation hépatique.